COVID-19 has given way to an unprecedented health care crisis, especially with regard to elderly persons aged 70 and above, who risk suffering from direct, more frequent and more serious complications from the infection than young persons would.
Furthermore, the current social distancing recommendations which are being undertaken as a preventative measure may increase the risk of indirect complications for elderly persons, such as lack of follow-up, greater risk of chronic illness decompensation due to health care channel reorganization and other factors, including anxiety, depressive symptomatology, nondisclosure of symptoms for fear of needing to travel to the hospital, poor access to medication due to confinement, lack of food…
WHAT IS ESOGER1© (FIRST LEVEL SOCIO-GERIATRIC EVALUATION IN PERIODS OF SOCIAL DISTANCING)?
The Centre of Excellence on Longevity at the McGill RUISSS designs and develops autonomy and human longevity tools to assist elderly persons, their caregivers, medical-social care professionals and communities. We have designed, tested and are now making available a socio-geriatric tracking tool for elderly persons, for use during the current isolation period, named ESOGER1.
ESOGER1 is a way to comprehensively and remotely evaluate the socio-geriatric situation of a specific elderly person, by determining possible complications and recommending action. It enables health care and social/administrative professionals to identify at risk elderly persons within their communities, and therefore to prioritize interventions in critical, overloaded times, such as the situation we are currently experiencing.
How does one use ESOGER1?ESOGER1 is a short (5 min) survey to be undertaken over the phone with the elderly person or a caregiver.
ESOGER1 enables us to ask the right questions, and identifies social and gerontological indicators which can be associated to specific levels of risk. These, in turn, will generate a result which can be immediately interpreted, or “risk score,” which proposes to trigger certain specific actions in response to certain results, such as communicating with a social centre or nurse, or requesting physician intervention…
ESOGER1 may be administered by medical personnel, but also by administrative and other non-medically trained personnel.
A hospital, administration or community could therefore, in periods of health, environmental or social crisis, continue or put in place essential follow-up procedures for isolated elderly persons with any available human resources.
Targeting the right persons, while forgetting none!
WHERE IS ESOGER1© FOUND?
ESOGER1 is freely available on the secure Centre of Excellence on Longevity Internet platform.
Access to ESOGER1 and its use are both free and anonymous. As required by applicable ethical and confidentiality regulations, none of the entered data will be saved by the platform.
You may complete ESOGER1 online and save the results on your computer (pdf) or in print.
AFTER ESOGER1©
ESOGER1 facilitates the tracking of isolated elderly persons who require help or intervention.
As a first level evaluation, ESOGER1 may not, should any doubt arise, replace REQUESTING ADVICE FROM A HEALTH OR SOCIAL CARE PROFESSIONAL.
EVOLUTION AND ACCESSIBILITY OF ESOGER1©
ESOGER1 has just been implemented and will frequently be improved and updated: do not hesitate to reach out to us if you wish to contribute to its improvement or be made aware of new versions.
ESOGER1 is available in both French and English. Should you wish to voluntarily translate the survey into another language, we will be more than happy to make it available online.
LEGAL NOTICE
ESOGER1© is the exclusive property of the Centre of Excellence on Longevity. We are pleased to make ESOGER1 available for free to any public or community organization who wishes to use it. We would appreciate that you mention that the ESOGER tool was developed by the Centre of Excellence on Longevity at the McGill RUISSS and to supply the following link: https://ceexlo.ca
The Centre of Excellence on Longevity cannot be held responsible for its fraudulent application or misuse. ESOGER1© has not yet been validated as a clinical tool, and as such the Centre of Excellence on Longevity may not be held liable with regard to any generated results or scores. ESOGER1 is a tracking tool, and it cannot guarantee the health and safety of the surveyed person. It does not dispense medical advice: ESOGER1 results must be validated by a health care professional.
Please see here for further provisions regarding any test performed on the ESOGER1 platform from France : RGPD Notices
